Daniel Ahmad, MD
Interventional Cardiology · Elgin, ILNPI 1386055622
Payments from drug & device makers
Across 453 payments — averaging $61.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Edwards Lifesciences$6K
- Boston Scientific$3K
- Abiomed$2K
- Penumbra, Inc.$1K
- Shockwave Medical, Inc$1K
- plus $7K from 35 others
What the payments were for
- Consulting fees$3,65013%
- Grants$4,50016%
- Travel & lodging$2,5229%
- Food & beverage$16,85860%
- Education$3901%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 34 | $7,582 |
| Edwards Lifesciences | 83 | $6,154 |
| Boston Scientific | 52 | $3,309 |
| Abiomed | 44 | $1,879 |
| Penumbra, Inc. | 4 | $1,227 |
| Shockwave Medical, Inc | 46 | $1,141 |
| Cook Medical LLC | 10 | $1,020 |
| Medtronic | 24 | $850 |
| Biotronik Inc. | 14 | $753 |
| Cardiovascular Systems Inc. | 18 | $450 |
| Acist Medical Systems, Inc. | 9 | $413 |
| AstraZeneca | 16 | $337 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $263 |
| Johnson & Johnson | 16 | $241 |
| Siemens Medical Solutions USA, Inc. | 4 | $224 |
| Asahi Intecc USA, Inc. | 2 | $221 |
| Chiesi USA, Inc. | 10 | $212 |
| Heartflow, Inc. | 8 | $198 |
| Jenavalve Technology, Inc. | 1 | $185 |
| Terumo Medical Corporation | 6 | $141 |
| W. L. Gore & Associates, Inc. | 5 | $135 |
| Novartis | 6 | $130 |
| Cardiva Medical, Inc. | 2 | $98 |
| E.r. Squibb & Sons, L.L.C. | 6 | $89 |
| Boehringer Ingelheim | 3 | $77 |
| Philips North America LLC | 2 | $67 |
| Reflow Medical Inc | 2 | $63 |
| Inari Medical, Inc. | 2 | $57 |
| Novo Nordisk | 2 | $50 |
| Cvrx, Inc. | 1 | $48 |
| Stryker | 1 | $46 |
| Amgen | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $36 |
| Scpharmaceuticals Inc. | 2 | $35 |
| AbbVie | 1 | $25 |
| Trevena, Inc. | 1 | $24 |
| Teleflex LLC | 1 | $24 |
| Pfizer | 1 | $24 |
| Imperative Care, Inc | 1 | $20 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
| Cordis US CORP. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$2,407
- AVVIGO Guidance System$1,719
- OPTIS$1,348
- Indigo System$1,147
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,051
- Impella$879
- Zilver PTX$711
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$589
- PRO-Kinetic Energy$239
- PK Papyrus$239
- PERIPHERAL VASCULAR$196
- JenaValve Pericardial TAVR System$185
- RESOLUTE ONYX$179
- Xience Sierra Coronary Stent$159
- MAMBA$159
- HD-IVUS$156
- COREVALVE EVOLUT R$154
- PERFORMER$143
- MitraClip$139
- Orsiro Mission$135
How this compares
$27,921 in reported general payments places this provider in the 70th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 94 | $66,263 |
| EliquisApixaban | 70 | $63,161 |
| EntrestoSacubitril/Valsartan | 35 | $35,274 |
| JardianceEmpagliflozin | 24 | $32,745 |
| Repatha SureclickEvolocumab | 15 | $16,240 |
| BrilintaTicagrelor | 23 | $12,849 |
| Metoprolol Succinate | 143 | $1,965 |
| Atorvastatin Calcium | 130 | $1,631 |
| Rosuvastatin Calcium | 88 | $1,206 |
| Nifedipine ErNifedipine | 50 | $933 |
| ClopidogrelClopidogrel Bisulfate | 78 | $782 |
| Losartan Potassium | 88 | $661 |
| Potassium Chloride | 16 | $533 |
| Amlodipine Besylate | 32 | $223 |
| Lisinopril | 31 | $215 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $241 | $66,26394 claims |
| PfizerEliquis | $24 | $63,16170 claims |
| NovartisEntresto | $130 | $35,27435 claims |
| Boehringer IngelheimJardiance | $77 | $32,74524 claims |
| AstraZenecaBrilinta | $337 | $12,84923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Elgin
- Charles DavidsonChicago$5.8M
- Ravi RamanaPalos Park$2.8M
- Mark RicciardiEvanston$2.2M
- Andrei PopElk Grove Village$1.9M
- Krishna Rocha SinghSpringfield$1.7M
- Bruce LewisMaywood$1.3M
- Justin LevisayEvanston$837K
- Atman ShahChicago$794K
- Laura DavidsonChicago$661K
- Sunil AgarwalSpringfield$609K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.